Health and Human Services Interim Committee - May 15, 2019

30 House Building

  Display documents automatically as they are discussed

This meeting is not currently streaming.

 Recording 1
 Chair Daw called the meeting to order at 8:39 a.m.
 Committee Business
 Rep. Miles moved to approve the November 26, 2018, meeting minutes.
 1.2 Approved Studies (Source: Legislative Management Committee)
 1.3 HHS issues addressed during the 2019 General Session (Source: OLRGC)
 Chair Daw discussed issues addressed during the 2019 General Session and the study items for the interim.
 Rep. Hollins moved to adopt the interim study items.
 Rep. Miles moved to authorize the chairs to open bill files.
 1.5 OPMA -- A Summary of Key Provisions for Legislators (Source: OLRGC)
 Mr. Daniel Cheung, Office of Legislative Research and General Counsel, summarized the Open and Public Meetings Act.
 Christensen et al. v. Miner et al - Update on Settlement Agreement & Action Plan
 2.1 Christensen et al. v. Miner et al. -- Summary of Settlement Agreement (Source: OLRGC)
 2.2 2019 H.J.R. 28, "Joint Resolution Regarding Approval of Settlement Agreement"
 2.3 DSPD Settlement Agreement and Action Plan (Source: Division of Services for People With Disabilities)
 2.4 Christensen v. Miner Settlement Appropriation (Source: Division of Services for People With Disabilities)
 Dr. Joseph K. Miner, Executive Director, Utah Department of Health, addressed the approved settlement agreement.
 Ms. Ann Silverberg Williamson, Executive Director, Utah Department of Human Services, stated the negotiations were not forced and were made with respect.
 Mr. Nate Checketts, Deputy Director, Utah Department of Health, explained the provisions of the settlement agreement and answered questions from the committee.
 Ms. Angie Pinna, Director, Division of Services for People With Disabilities, explained the provisions of the settlement agreement and answered questions from the committee.
 Medicaid - Oversight of Eligibility Expansion
 3.1 Utah's Medicaid Expansion: Implementation Toolkit (includes "At a Glance" summary of S.B. 96 waiver requirements and FAQs) (Source: Utah Department of Health)
 3.2 Federal approval letter for 04/01/19 Medicaid expansion (Source: Centers for Medicare and Medicaid Services)
 Mr. Nate Checketts explained the Medicaid expansion and the provisions of the expansion.
 Medical Cannabis - Implementation of Recent Amendments
 2018 H.B. 3001, Utah Medical Cannabis Act (Hughes)
 2019 S.B. 105, Hemp and Cannabinoid Act Amendments (Vickers)
 2019 S.B. 161, Medical Cannabis Act Amendments (Escamilla)
 2019 S.C.R. 7, Concurrent Resolution Urging Legal Medical Cannabis Banking (Anderegg)
 4.1 2018 H.B. 3001 summary (graphic) (Source: OLRGC)
 4.2 2018 H.B. 3001 summary (text) (Source: OLRGC)
 4.3 Fact Sheet (Source: Utah Department of Health)
 4.4 FAQs (Source: Utah Department of Health)
 Ms. Deborah Blackburn, Regulatory and Compliance Officer, Division of Occupational and Professional Licensing, addressed the licenses issued to those authorized to provide cannabis.
 4.5 Utah Medical Cannabis Program Act: Program Update (Source: Utah Department of Agriculture and Food)
 Mr. Andrew Rigby, Utah Department of Agriculture and Food, provided an update on the impact of the Utah Medical Cannabis Act and how the department is meeting deadlines.
 Rep. Thurston moved to open a committee bill file to address potential law changes needed by the Department of Agriculture and Food.
 4.6 Utah Medical Cannabis Act: Implementation Update (Source: Utah Department of Health)
 Dr. Marc Babitz, MD, Deputy Director, Utah Department of Health, addressed the implementation update for the Utah Medical Cannabis Act by the Utah Department of Health.
 Mr. Rich Oborn, Director, Center for Medical Cannabis, provided information on the purpose of the Center for Medical Cannabis and information on the Compassionate Use Board and answered questions from the committee.
 Ms. Christine Stenquist, TRUCE, asked if the recommended physicians have continuing education credit hours in studying medical cannabis.
 Dr. Ed Redd, Chair, Utah Cannabinoid Product Board, provided information on the board and it's role.
 4.7 Treatment of Chronic Pain With CBD and THC (Source: Yurgelun-Todd, Renshaw)
 Dr. Deborah Yugelun-Todd, Professor of Psychiatry, provided an update on the previously funded study to look at the effect of marijuana on pain.
 Dr. Perry Renshaw, Professor of Psychiatry, provided additional information on the project.
 Mr. Connor Boyack, President, Libertas Institute, and advisor to the Utah Patients Coalition, stated the Utah Patients Coalition had an opportunity to provide the Utah Department Health with input as to who ended up on the Compassionate Use Board.
 Rep. Thurston moved to open a committee bill file to study the impact of pharmacy transparency pricing to lower costs.
 Adjourn
 Sen. Christensen moved to adjourn.
 Chair Daw adjourned the meeting at 11:06 a.m.
Recording 1 - Low Quality     

Having trouble listening? Try our troubleshooting page.